ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,647Medicare Part D Prescriptions Filled, Including Refills

Rank: 173 out of 1269

$573K Total Retail Price of All Prescriptions

Rank: 108 out of 1269

420 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
25% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 420 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

4% of this provider’s 420 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 5,893 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$86 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
LEVOTHYROXINE SODIUM 275 269 1 4
SIMVASTATIN 209 181 2 3
LISINOPRIL 207 188 3 1
WARFARIN SODIUM 175 167 4 12
AMLODIPINE BESYLATE 174 172 5 2
METOPROLOL SUCCINATE 143 110 6 13
FUROSEMIDE 136 131 7 5
ATORVASTATIN CALCIUM 134 118 8 7
PANTOPRAZOLE SODIUM 127 108 9 18
OMEPRAZOLE 122 117 10 8
METOPROLOL TARTRATE 118 117 11 6
CRESTOR 107 84 12 25
SERTRALINE HCL 100 100 13 23
ZOLPIDEM TARTRATE 99 73 14 19
MIRTAZAPINE 91 91 15 24
LOSARTAN POTASSIUM 87 82 16 15
POLYETHYLENE GLYCOL 3350 79 66 17 50
DIOVAN 79 62 17 35
FLUTICASONE PROPIONATE 78 33 19 40
DONEPEZIL HCL 77 74 20 22
CITALOPRAM HBR 70 70 21 21
HYDROCHLOROTHIAZIDE 70 64 21 10
DIVALPROEX SODIUM 69 64 23 54
MELOXICAM 66 51 24 68
CLOPIDOGREL 64 64 25 32
SEROQUEL 64 62 25 104
SPIRIVA 64 48 25 64
ADVAIR DISKUS 62 52 28 46
NEXIUM 60 33 29 41
GABAPENTIN 58 49 30 17
LACTULOSE 58 40 30 67
PLAVIX 57 55 32 47
PRAVASTATIN SODIUM 55 55 33 11
QUETIAPINE FUMARATE 55 52 33 53
LOSARTAN-HYDROCHLOROTHIAZIDE 54 54 35 59
ALENDRONATE SODIUM 54 52 35 28
ATENOLOL 51 51 37 14
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.